ROR1 and neoplasm: When T-cells engineered to express this CAR were co-cultured with the ROR1+ breast cancer cell line MDA-MB-231, they exhibited rapid proliferation, high levels of IFN-γ and IL-2, and the ability to kill the tumor cells (104).